Ligand Pharmaceuticals Incorporated
$5.36B- Market cap
- $5.72B
- Debt
- +$374.08M
- Cash
- −$733.52M
Capital structure 94% equity / 6% debt · EV / Revenue 19.98x · EV / EBITDA 33.42x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
LGND · price snapshotP/E 46.78x
$286.74Snapshot Sep 8, 2026, 2:32 PM ET
Implied fair value · at NYT's multiple
$197.5431.1% below market
6.13 LGND Annual EPS×32.22x NYT P/E=$197.54
Market $286.74Implied $197.54
NYT · price snapshotP/E 32.22x
$67.35Snapshot Sep 8, 2026, 2:33 PM ET
Implied fair value · at LGND's multiple
$97.7645.2% above market
2.09 NYT Annual EPS×46.78x LGND P/E=$97.76
Market $67.35Implied $97.76